Endurant Capital Management as of June 30, 2018
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 65 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allergan | 8.3 | $19M | 115k | 166.72 | |
| Merck & Co (MRK) | 6.8 | $16M | 258k | 60.70 | |
| Abbott Laboratories (ABT) | 6.8 | $16M | 256k | 60.99 | |
| Shire | 5.0 | $12M | 68k | 168.80 | |
| CIGNA Corporation | 4.8 | $11M | 65k | 169.95 | |
| Medtronic (MDT) | 4.6 | $11M | 125k | 85.61 | |
| DaVita (DVA) | 4.2 | $9.6M | 139k | 69.44 | |
| Anthem (ELV) | 3.8 | $8.8M | 37k | 238.03 | |
| Universal Health Services (UHS) | 3.1 | $7.2M | 64k | 111.44 | |
| Johnson & Johnson (JNJ) | 3.1 | $7.1M | 59k | 121.34 | |
| CVS Caremark Corporation (CVS) | 3.0 | $6.9M | 107k | 64.35 | |
| Mylan Nv | 2.8 | $6.5M | 179k | 36.14 | |
| Baxter International (BAX) | 2.6 | $5.9M | 80k | 73.84 | |
| Gilead Sciences (GILD) | 2.5 | $5.9M | 83k | 70.84 | |
| Celgene Corporation | 2.5 | $5.7M | 71k | 79.42 | |
| Tivity Health | 2.4 | $5.6M | 160k | 35.20 | |
| Aetna | 2.3 | $5.4M | 29k | 183.51 | |
| UnitedHealth (UNH) | 1.8 | $4.1M | 17k | 245.33 | |
| Becton, Dickinson and (BDX) | 1.8 | $4.0M | 17k | 239.54 | |
| Hill-Rom Holdings | 1.6 | $3.7M | 43k | 87.34 | |
| Hologic (HOLX) | 1.4 | $3.3M | 84k | 39.75 | |
| Iqvia Holdings (IQV) | 1.4 | $3.3M | 33k | 99.83 | |
| Hca Holdings (HCA) | 1.4 | $3.2M | 31k | 102.58 | |
| Wright Medical Group Nv | 1.2 | $2.8M | 108k | 25.96 | |
| Zimmer Holdings (ZBH) | 1.1 | $2.5M | 23k | 111.46 | |
| Puma Biotechnology (PBYI) | 1.1 | $2.4M | 41k | 59.16 | |
| Boston Scientific Corporation (BSX) | 1.0 | $2.4M | 73k | 32.70 | |
| Cooper Companies | 1.0 | $2.2M | 9.4k | 235.44 | |
| Centene Corporation (CNC) | 0.9 | $2.2M | 18k | 123.22 | |
| Oxford Immunotec Global | 0.9 | $2.0M | 157k | 12.89 | |
| Sabra Health Care REIT (SBRA) | 0.9 | $2.0M | 91k | 21.73 | |
| Syneos Health | 0.8 | $1.8M | 39k | 46.89 | |
| Regeneron Pharmaceuticals (REGN) | 0.8 | $1.8M | 5.3k | 344.91 | |
| Agilent Technologies Inc C ommon (A) | 0.8 | $1.8M | 29k | 61.85 | |
| Express Scripts Holding | 0.8 | $1.8M | 23k | 77.20 | |
| Walgreen Boots Alliance (WBA) | 0.8 | $1.7M | 29k | 60.00 | |
| McKesson Corporation (MCK) | 0.7 | $1.7M | 13k | 133.42 | |
| Stryker Corporation (SYK) | 0.7 | $1.6M | 9.4k | 168.91 | |
| Endologix Inc note 2.250%12/1 | 0.7 | $1.5M | 1.5M | 0.99 | |
| Pra Health Sciences | 0.6 | $1.4M | 15k | 93.38 | |
| Clovis Oncology | 0.6 | $1.4M | 31k | 45.48 | |
| Array BioPharma | 0.6 | $1.4M | 81k | 16.78 | |
| Pfizer (PFE) | 0.5 | $1.2M | 34k | 36.28 | |
| Valeant Pharmaceuticals Int | 0.5 | $1.1M | 47k | 23.25 | |
| Ocular Therapeutix (OCUL) | 0.4 | $964k | 143k | 6.75 | |
| Fate Therapeutics (FATE) | 0.4 | $936k | 83k | 11.34 | |
| Mallinckrodt Pub | 0.4 | $909k | 49k | 18.66 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $887k | 6.7k | 132.11 | |
| Amicus Therapeutics (FOLD) | 0.4 | $851k | 55k | 15.61 | |
| Nevro (NVRO) | 0.3 | $806k | 10k | 79.83 | |
| Portola Pharmaceuticals | 0.3 | $786k | 21k | 37.78 | |
| Thermo Fisher Scientific (TMO) | 0.3 | $706k | 3.4k | 207.22 | |
| ImmunoGen | 0.3 | $664k | 68k | 9.73 | |
| D Fluidigm Corp Del (LAB) | 0.3 | $680k | 114k | 5.96 | |
| Viking Therapeutics (VKTX) | 0.2 | $574k | 61k | 9.49 | |
| Bellicum Pharma | 0.2 | $530k | 72k | 7.38 | |
| Mednax (MD) | 0.2 | $409k | 9.4k | 43.32 | |
| Nektar Therapeutics (NKTR) | 0.2 | $386k | 7.9k | 48.86 | |
| Heron Therapeutics (HRTX) | 0.1 | $343k | 8.8k | 38.87 | |
| Akari Therapeutics | 0.1 | $352k | 180k | 1.95 | |
| AmerisourceBergen (COR) | 0.1 | $315k | 3.7k | 85.32 | |
| Clearside Biomedical (CLSD) | 0.1 | $314k | 29k | 10.68 | |
| Zogenix | 0.1 | $286k | 6.5k | 44.18 | |
| Laboratory Corp. of America Holdings (LH) | 0.1 | $224k | 1.2k | 179.34 | |
| Histogenics Corp Cmn | 0.1 | $140k | 56k | 2.49 |
